What it is
MDMA is a synthetic drug that combines stimulant effects with warmth, closeness and altered perception. It is sold as pressed tablets (ecstasy) or crystal powder (molly). It has no approved medical use in the US. In August 2024 the FDA declined to approve MDMA-assisted therapy for PTSD and asked for another trial.
How it works
MDMA releases serotonin as well as dopamine and norepinephrine. Effects start in 30 to 45 minutes and last 4 to 6 hours, often followed by low mood for days as serotonin recovers. The body converts a small part of MDMA into MDA, a related drug. That is why federal labs test for both, and why the AMP strip can react.
How it is used
- Swallowed as tablets or capsules at parties, clubs and festivals
- Redosed through the night to extend effects
- Combined with alcohol, marijuana or other drugs
- Taken unknowingly as pills that contain other drugs
Effects and warning signs
- Jaw clenching, teeth grinding, dilated pupils
- Overheating and dehydration
- Drinking too much water, causing dangerously low sodium
- Days later: fatigue, low mood, poor concentration
Why it matters at work
- Use is mostly weekend and occasional
- Short detection window, so urine rarely catches it
- Adulterated pills can expose users to meth or fentanyl
The Labb MDMA test
An MDMA result is a Non-Negative screen until a laboratory confirms it. There is no prescription that explains a confirmed MDMA. Why a separate strip: the MET strip only reacts to MDMA at high levels, and AMP only catches the small amount of MDA. The MDMA strip catches use those two miss.
| Kit | Specimen | Cutoff (ng/mL) |
|---|---|---|
| eTest Swab OR:12A | Oral fluid | 50 |
| eTest Swab OR:14A | Oral fluid | 50 |
| eTest Cup UA:13A SVT | Urine | 500 |
| eTest Cup UA:15A | Urine | 500 |
| eTest Cup UA:16C SVT | Urine | 500 |
| eTest Cup UA:18C SVT | Urine | 150 |
This profile is educational and does not replace a package insert, laboratory guidance or medical advice. A rapid test result is a Non-Negative screen until a laboratory confirms it.
